现代检验医学杂志2024,Vol.39Issue(4) :165-169.DOI:10.3969/j.issn.1671-7414.2024.04.030

绝经后骨质疏松症患者血清CCL2,CX3CL1和CXCL10的水平表达及对骨折发生的预测价值

Expression Levels of Serum CCL2,CX3CL1 and CXCL10 in Postmenopausal Osteoporosis Patients and Their Predictive Value for Fracture Occurrence

张恒林 吴克第 王声威 刘景新
现代检验医学杂志2024,Vol.39Issue(4) :165-169.DOI:10.3969/j.issn.1671-7414.2024.04.030

绝经后骨质疏松症患者血清CCL2,CX3CL1和CXCL10的水平表达及对骨折发生的预测价值

Expression Levels of Serum CCL2,CX3CL1 and CXCL10 in Postmenopausal Osteoporosis Patients and Their Predictive Value for Fracture Occurrence

张恒林 1吴克第 1王声威 1刘景新1
扫码查看

作者信息

  • 1. 海南西部中心医院骨科,海南儋州 571799
  • 折叠

摘要

目的 探讨血清CC趋化因子配体2(CC chemokine ligand 2,CCL2)、CX3C趋化因子配体1(CX3C chemokine ligand 1,CX3CL1)及 CXC 趋化因子配体 10(CXC chemokine ligand 10,CXCL10)在绝经后骨质疏松症(postmenopausal osteoporosis,PMOP)患者中的表达及其联合骨折风险评估工具(fracture risk assessment tool,FRAX)预测骨折发生的价值.方法 选取2022年1月~2023年6月海南西部中心医院收治的PMOP患者120例,根据其发生骨折情况分为骨折组(n=52)和未骨折组(n=68),根据FRAX评分检查分为骨折高风险组(n=73)和骨折低风险组(n=47).比较各组血清CCL2,CX3CL1及CXCL10水平.多因素Logistic回归分析影响PMOP患者发生骨折的危险因素,绘制ROC曲线分析CCL2,CX3CL1及CXCL10联合FRAX评分预测PMOP发生骨折的价值.结果 骨折组血清 CCL2(134.98±32.24 pg/ml),CX3CL1(186.25±41.60 pg/ml)及 CXCL10(223.47±56.43 pg/ml)水平均明显高于未骨折组(82.26±17.30 pg/ml,105.23±23.78 pg/ml,151.47±43.14 pg/ml),差异具有统计学意义(t=11.503,13.452,7.923,均 P<0.001).骨折高风险组血清 CCL2(119.70±37.56 pg/ml),CX3CL1(161.43±53.79 pg/ml)及 CXCL10(204.06±61.41 pg/ml)水平均明显高于低风险组(82.43±17.23 pg/ml,107.55±24.75 pg/ml,149.45±42.50pg/ml),差异具有统计学意义(t=6.377,6.436,5.327,均 P<0.001).多因素 Logistic 回归分析显示,血清CCL2,CX3CL1及CXCL10水平升高是影响PMOP患者发生骨折的危险因素.ROC曲线显示,CCL2,CX3CL1及CXCL10联合FRAX评分预测PMOP发生骨折的AUC(95%CI)最大[0.951(0.892~0.993)],其敏感度和特异度分别为98.2%,85.6%.结论 血清CCL2,CX3CL1及CXCL10水平升高是影响PMOP患者发生骨折的危险因素,联合FRAX评分对骨折具有较好的预测价值.

Abstract

Objective To investigate the expression of serum CC chemokine ligand 2(CCL2),CX3C chemokine ligand 1(CX3CL1)and CXC chemokine ligand 10(CXCL10)in postmenopausal osteoporosis(PMOP)patients and the value of combination with fracture risk assessment tool(FRAX)in predicting fracture occurrence.Methods A total of 120 patients with PMOP admitted to Hainan West Central Hospital from January 2022 to June 2023 were selected,and they were divided into fracture group(n=52)and non-fracture group(n=68).According to the FRAX score examination,they were divided into a high-risk fracture group(n=73)and a low-risk fracture group(n=47).The levels of serum CCL2,CX3CL1 and CXCL10 in each group were compared.Multivariate Logistic regression was used to analyze the fracture risk factors in PMOP patients.ROC curve was drawn to analyze the value of CCL2,CX3CL1 and CXCL10 combined with FRAX score in predicting fracture of PMOP.Results The levels of serum CCL2(134.98±32.24 pg/ml),CX3CL1(186.25±41.60 pg/ml)and CXCL10(223.47±56.43 pg/ml)in the fracture group were higher than those in the non-fracture group(82.26±17.30 pg/ml,105.23±23.78 pg/ml,151.47±43.14 pg/ml),and the differences were statistically significant(t=11.503,13.452,7.923,all P<0.001).The levels of serum CCL2(119.70±37.56 pg/ml),CX3CL1(161.43±53.79 pg/ml)and CXCL10(204.06±61.41pg/ml)in the high-risk group for fractures were higher than those in the low-risk group(82.43±17.23 pg/ml,107.55±24.75 pg/ml,149.45±42.50pg/ml),and the differences were statistically significant(t=6.377,6.436,5.327,all P<0.001).Multivariate Logistic regression analysis showed that elevated levels of serum CCL2,CX3CL1 and CXCL10 were risk factors for fractures in PMOP patients.The ROC curve showed that the combination of CCL2,CX3CL1 and CXCL10 combined with FRAX scores predicted the highest AUC(95%CI)for PMOP fractures[0.951(0.892~0.993)],with sensitivity and specificity of 98.2%and 85.6%,respectively.Conclusion The increased levels of serum CCL2,CX3CL1 and CXCL10 are risk factors for fracture in PMOP patients,and the combination with FRAX score has a good predictive value for fracture.

关键词

绝经后骨质疏松症/骨折/CC趋化因子配体2/CX3C趋化因子配体1/CXC趋化因子配体10

Key words

postmenopausal osteoporosis/fracture/CC chemokine ligand 2/CX3C chemokine ligand 1/CXC chemokine ligand 10

引用本文复制引用

基金项目

海南省医药卫生科研基金项目(20A200008)

出版年

2024
现代检验医学杂志
陕西省临床检验中心,陕西省人民医院

现代检验医学杂志

CSTPCD
影响因子:0.713
ISSN:1671-7414
段落导航相关论文